INBX
Price
$28.20
Change
+$0.32 (+1.15%)
Updated
Aug 29 closing price
Capitalization
408.49M
74 days until earnings call
SRZN
Price
$12.19
Change
+$0.51 (+4.37%)
Updated
Aug 29 closing price
Capitalization
104.43M
Interact to see
Advertisement

INBX vs SRZN

Header iconINBX vs SRZN Comparison
Open Charts INBX vs SRZNBanner chart's image
Inhibrx Biosciences
Price$28.20
Change+$0.32 (+1.15%)
Volume$77.07K
Capitalization408.49M
Surrozen
Price$12.19
Change+$0.51 (+4.37%)
Volume$33.32K
Capitalization104.43M
INBX vs SRZN Comparison Chart in %
Loading...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INBX vs. SRZN commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INBX is a Buy and SRZN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (INBX: $28.20 vs. SRZN: $12.19)
Brand notoriety: INBX and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INBX: 64% vs. SRZN: 208%
Market capitalization -- INBX: $408.49M vs. SRZN: $104.43M
INBX [@Biotechnology] is valued at $408.49M. SRZN’s [@Biotechnology] market capitalization is $104.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INBX’s FA Score shows that 1 FA rating(s) are green whileSRZN’s FA Score has 1 green FA rating(s).

  • INBX’s FA Score: 1 green, 4 red.
  • SRZN’s FA Score: 1 green, 4 red.
According to our system of comparison, both INBX and SRZN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INBX’s TA Score shows that 4 TA indicator(s) are bullish while SRZN’s TA Score has 2 bullish TA indicator(s).

  • INBX’s TA Score: 4 bullish, 4 bearish.
  • SRZN’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, INBX is a better buy in the short-term than SRZN.

Price Growth

INBX (@Biotechnology) experienced а +12.80% price change this week, while SRZN (@Biotechnology) price change was +6.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

INBX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($408M) has a higher market cap than SRZN($104M). INBX YTD gains are higher at: 83.117 vs. SRZN (-15.087). SRZN has higher annual earnings (EBITDA): -24.83M vs. INBX (-155.08M). INBX has more cash in the bank: 187M vs. SRZN (90.4M). SRZN has less debt than INBX: SRZN (7.51M) vs INBX (107M). SRZN has higher revenues than INBX: SRZN (12.6M) vs INBX (1.4M).
INBXSRZNINBX / SRZN
Capitalization408M104M392%
EBITDA-155.08M-24.83M624%
Gain YTD83.117-15.087-551%
P/E Ratio0.20N/A-
Revenue1.4M12.6M11%
Total Cash187M90.4M207%
Total Debt107M7.51M1,424%
TECHNICAL ANALYSIS
Technical Analysis
INBXSRZN
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 26 days ago
82%
Bearish Trend 24 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMYRX13.12N/A
N/A
Victory Pioneer Equ Premium Income Y
GMCFX31.82-0.17
-0.53%
GMO International Equity IV
BMDIX23.16-0.14
-0.60%
Baird Mid Cap Growth Institutional
GCCLX22.70-0.19
-0.83%
GMO Climate Change I
FKACX34.09-0.44
-1.27%
Franklin Growth Opportunities C

INBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if INBX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
+1.15%
AXON - INBX
48%
Loosely correlated
-4.43%
AKESF - INBX
45%
Loosely correlated
+8.70%
COGT - INBX
43%
Loosely correlated
N/A
SNTI - INBX
39%
Loosely correlated
-5.16%
ACET - INBX
38%
Loosely correlated
-5.09%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with IRON. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+4.32%
IRON - SRZN
34%
Loosely correlated
-0.03%
ELDN - SRZN
32%
Poorly correlated
+0.78%
ABCZF - SRZN
28%
Poorly correlated
N/A
KMSTF - SRZN
27%
Poorly correlated
N/A
DWTX - SRZN
27%
Poorly correlated
+3.44%
More